By InvitationNot Applicable

Emotional Release After Trigger Point Needling to Treat Myofascial Pain of the Head and Neck - Prospective Study

Israel100 participantsStarted 2025-03-13

Plain-language summary

Temporomandibular Dysfunction (TMD) as classified by the DC-TMD has a significant psychosocial component referred to as "Axis II". One of the methods of treatment for myofascial TMD is "needing" which could be "dry needling" using only a needle or "wet needling" using local anesthetics. Practitioners of needling commonly observe an emotional release by the patient undergoing needling. This study aims to record and measure the emotional state of patients just before and just after needling for myofascial TMD via questionnaires.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: The study group will include patients which consent to the study and are diagnosed with: Myalgia/Local Myalgia or Myofascial Pain or Myofascial pain with referral or Headache attributed to TMD with or without concurrent diagnosis related to the temporomandibular joint itself. Exclusion Criteria: Patients who are not eligible for IMS therapy will be excluded: * PLT count under 80,000 * Active or chronic infection at site of pain * Known allergy to amide local anesthetics * Severe bleeding disorder such as Hemophilia * If treated with Warfarin INR over 3

What they're measuring

Shift in mood state

Timeframe: From enrollment to the end of the needling session (4-8 weeks)

Pain reducation

Timeframe: From enrollment to the end of the needling session (4-8 weeks)

Trial details

NCT IDNCT06912438

SponsorTel-Aviv Sourasky Medical Center

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2027-03-13

View on ClinicalTrials.gov More Temporomandibular Disorders (TMD) trials